Curi Bio Announced 2021 Edison Award Finalist
Curi Bio is honored to be announced a 2021 Edison Award Finalist! This award recognizes our innovative Mantarray technology.
SEATTLE—Curi Bio, a leading developer of human stem cell-based biotechnology products and services for drug discovery and development, announced today that it was selected as a finalist and winner of the 2021 Edison Award. Curi’s innovation team behind the nominated product, Mantarray™, will be recognized with either a Gold, Silver, or Bronze award in the category of Science, Medical, and Dental (IoT) on April 22, 2021 at Awards Ceremony in Fort Myers, Florida.
Mantarray technology in action.
Originally established in 1987, the Edison Awards™ have recognized and honored some of the most innovative products, services, and business leaders from around the world and is among the most prestigious accolades honoring excellence in new product and service development, marketing, design, and innovation.
After reviewing more than 7,000 products and services and accepting over 400 nominations, we would like to personally congratulate your team on all of your success and commitment to innovation. This award recognizes Curi Bio’s hand in shaping the industry.
To learn more about Edison Awards, visit this webpage.
About Curi Bio
Curi Bio’s preclinical discovery platform combines human stem cells, systems, and data to accelerate the discovery of new medicines. Curi’s suite of human stem cell maturation platforms and services enable scientists to build more mature and predictive human stem cell-derived tissues—with a focus on cardiac, musculoskeletal, and neuromuscular models—for the discovery, safety testing, and efficacy testing of new drugs in development. Drug developers can access an integrated preclinical discovery platform with highly predictive human stem cell models to generate clinically-relevant data. Curi is closing the gap between preclinical data and human results, accelerating the discovery and development of safer, more effective medicines.
For more information, please visit www.curibio.com.